040760 UK Health- and Pharmaceutical Economics (BA) (2023S)
Continuous assessment of course work
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Mo 13.02.2023 09:00 to We 22.02.2023 12:00
- Deregistration possible until Fr 17.03.2023 23:59
Details
max. 30 participants
Language: German
Lecturers
Classes (iCal) - next class is marked with N
- Friday 17.03. 13:15 - 18:15 Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
- Saturday 18.03. 09:45 - 13:00 Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
- Friday 05.05. 13:15 - 18:15 Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
- Saturday 06.05. 09:45 - 13:00 Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
- Friday 09.06. 13:15 - 18:15 Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
- Saturday 10.06. 09:45 - 11:15 Hörsaal 15 Oskar-Morgenstern-Platz 1 2.Stock
Information
Aims, contents and method of the course
Assessment and permitted materials
Assigned Presentation (15 -20 Min)
Written final Exam
Written final Exam
Minimum requirements and assessment criteria
Presentation and exam both contribute 50% to final grade.
To achieve a positive grade in the test, at least 50% of the points in the written test are necessary
To achieve a positive grade in the test, at least 50% of the points in the written test are necessary
Examination topics
Reading list
Foliensatz wird auf moodle bereitgestelltZusätzlich:
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)
Association in the course directory
Last modified: Tu 14.03.2023 11:28
• Forms of Delivery of Medical Care
• Paying Providers
• Physicians as Suppliers of Medical Services
• Austrian Health Care System
Literature:
Breyer, F./Zweifel, P. Kifmann, M (2013), Gesundheitsökonomik, Springer. (Chapters 8, 10, 12)Part 2: Health Economic Evaluation
• Health Technology Assessment (HTA) across countries
• Cost Effectiveness analysis
• Cost utility analysis
• Cost benefit analysis
• Comparative effectiveness
• Decision analytic modeling (e.g. Markov Models)
• Evidenced based Medicine
Literature:
Drummond, M/Sculpher, M./Torrance, G./O’Brien, B./Stoddart, G. (2015), Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press (Chapters 5, 6, 7, 9)
Additional reading:
Schöffski, O. Graf v.d. Schulenburg, M. (Hg.) (2008), Gesundheitsökonomische Evaluationen, Springer.Part 3 Pharmaceutical Economics
• The pharmaceutical Industry
• Pharmaceutical R&D process
• Costs and returns on pharmaceutical R&D
• Pricing Pharmaceuticals
• Pharmaceutical Regulation (e.g. patent legislation)
• Drug MarketingLiterature:
Schweitzer, S. (2007), Pharmaceutical Economics and Policy, Oxford University Press. (Chapters 1, 4, 6, 8, 12)